A Prospective Randomized Double-Blinded Placebo Controlled, Explorative Phase I Trial to Investigate the Safety and Tolerability of Two Different Doses of Topically Administered APOSEC™ in Healthy Male Subjects With Artificial Dermal Wounds
PHASE1
This is a prospective, single center, randomized, double-blinded, placebo-c...
Status
Completed
Location
Medical University of Vienna, Department of Clinical Pharmacology
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
PHASE3
This is a randomized, double-blind, study that compares pembrolizumab (MK-3...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 1562)